Treatment-related fluctuations in subacute inflammatory demyelinating polyneuropathy

Ropper, 1988, Limited relapse in Guillain-Barré syndrome after plasma exchange, Arch. Neurol., 45, 314, 10.1001/archneur.1988.00520270096026 Kleyweg, 1991, Treatment-related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange, J. Neurol. Neurosurg. Psychiatry, 54, 957, 10.1136/jnnp.54.11.957 Visser, 1998, The Dutch Guillain-Barré study group. Risk factors for treatment-related clinical fluctuations in Guillain-Barré syndrome, J. Neurol. Neurosurg. Psychiatry, 64, 242, 10.1136/jnnp.64.2.242 Ruts, 2005, Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations, Neurology, 65, 138, 10.1212/01.wnl.0000167549.09664.b8 Ruts, 2010, Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study, Neurology, 74, 1680, 10.1212/WNL.0b013e3181e07d14 Inoue, 2003, Dissociation between titer of anti-ganglioside antibody and severity of symptoms in a case of Guillain-Barré syndrome with treatment-related fluctuation, J. Neurol. Sci., 210, 105, 10.1016/S0022-510X(03)00031-5 Kuitwaard, 2009, Recurrent Guillain–Barré syndrome, J. Neurol. Neurosurg. Psychiatry, 80, 56, 10.1136/jnnp.2008.156463 Oh, 2003, Subacute inflammatory demyelinating polyneuropathy, Neurology, 61, 1507, 10.1212/01.WNL.0000096166.28131.4C